As an approach for the PCF detection abbreviated from pancreatic cyst fluid, NGS has recognized KRAS mutations providing 96%–100% specificity and 76%–89% sensitivity for MCNs and BD‐IPMNs [108, 109]. The gene discussed is KRAS; the disease is Pancreatic cysts.